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disease. Using quantile regression analysis, equations for the 
median and lower limit of normal were derived for indices 
characterizing the expiratory flow-volume curve: forced ex-
piratory volume in 1 s (FEV 1 ), forced vital capacity (FVC), FEV 1 /
FVC, peak expiratory flow (PEF), and forced expiratory flow 
rates at 25, 50 and 75% of exhaled FVC (FEF 25 , FEF 50 and 
FEF 75 ).  Results: FEV 1 and FVC were slightly higher, and PEF 
was lower compared to recently published equations. Im-
portantly, forced expiratory flow rates at middle and low 
lung volume, as putative indicators of small airway disease, 
were in good agreement with recent data, especially for old-
er age.  Conclusion: Our study provides up-to-date reference 
equations for all major indices of flow-volume curves in mid-
dle and advanced age in a South German population. The 
small deviations from published equations indicate that 
there might be some regional differences of lung function 
within the Caucasian population of advanced age in Europe. 
 Copyright © 2012 S. Karger AG, Basel 
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 Abstract 
 Background: The diagnostic use of lung function using spi-
rometry depends on the validity of reference equations. A 
multitude of spirometric prediction values have been pub-
lished, but in most of these studies older age groups are un-
derrepresented.  Objectives: The aim of the present study 
was to establish new spirometric reference values for ad-
vanced age and to compare these to recent prediction equa-
tions from population-based studies.  Methods: In the pres-
ent study spirometry was performed in a population-based 
sample from the KORA-F4 and KORA-Age cohorts (2006–
2009, Augsburg, Germany) comprising 592 never-smoking 
subjects aged 42–89 years and with no history of respiratory 
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 Introduction 
 Spirometry still is the basis of lung function assess-
ment in clinical practice and epidemiology. The adequacy 
of reference values is essential for the correct interpreta-
tion of these measurements and ATS/ERS guidelines 
have recommended the application of population-specif-
ic reference equations in Europe  [1] . In the last decade, 
several studies – among them studies from Switzerland 
 [2] and Germany  [3] that include subjects over 70 years of 
age – have generated up-to-date reference values. These 
have revealed that, for example, the equations from the 
European Community of Coal and Steel (ECCS)  [4] , 
which still are widely used in Europe, nowadays yield val-
ues which are too low, particularly those of FVC and 
FEV 1  [2, 3, 5–7] . Moreover, an initiative has been started 
to collate data from a multitude of studies performed 
worldwide to derive adequate reference values for all age 
ranges  [8] .
 In many of the existing studies, subjects of advanced 
age of over 70 years are underrepresented compared to 
younger individuals. Depending on the applied statistical 
instruments, this can lead to inadequate reference equa-
tions for this age group, which is of relevance in view of 
the ageing populations in many countries. Of particular 
value would be validated reference data for the various 
forced expiratory flow rates in subjects of this advanced 
age. These measures are often considered as indicative of 
the beginning of small airway disease  [9] but heavily de-
pend on the cooperation of the subjects. It is, therefore, of 
special importance to achieve a high quality of measure-
ments and of subject characterization.
 The present study aims to bridge this gap by providing 
up-to-date reference equations of flow-volume curves for 
subjects over the age of 45 years. Data were taken from a 
random population sample of the Augsburg region in 
Southern Germany, with an approximately equal repre-
sentation of middle and advanced age. The results were 
compared with ECCS  [4] predictions and recent equa-
tions from population-based studies including a higher 
number of older adults  [2, 3, 5, 6] .
 Methods 
 Assessment of Lung Function 
 Indices of the flow-volume curve were assessed in two stud-
ies covering different age ranges. In KORA-F4, 1,321 subjects
aged 41–63 years were examined between 2006 and 2008, and in 
KORA-Age, 935 subjects aged 65–90 years were examined in 
2009. Measurement conditions including the major examiners 
were the same in both studies. KORA-F4 and KORA-Age were 
based on a representative population cohort from the Augsburg 
region (KORA, Cooperative Health Research in the Augsburg Re-
gion, Germany) and were follow-up studies of the MONICA/
KORA surveys S1–S4. Both studies were approved by the Ethics 
Committee of the Bavarian Medical Association. Details of the 
KORA platform and surveys have been described previously  [10, 
11] . The subjects of both studies were recruited in separate age 
groups to achieve an equal distribution over the age range. There 
was only a minor gap between 62 and 65 years at the interface be-
tween both studies.
 Standard spirometry was performed in line with the ATS/ERS 
recommendations  [12] in a sitting position while subjects were 
wearing noseclips. The procedure was performed using a pneu-
motachograph-type spirometer (Masterscope PC; CareFusion, 
Höchberg, Germany) with a resistance of 0.05 kPa  l –1  s –1 at 10 
l  s –1 and a volume accuracy of  8 5 ml. While bronchodilation 
with 200   g salbutamol was performed in 71% of subjects from 
the KORA-F4 cohort, only prebronchodilator results were used 
for the current combined analysis of both cohorts. We put par-
ticular emphasis on obtaining optimal flow-volume curves in up 
to 8 trials under the guidance of specifically trained and experi-
enced personnel. The participants performed at least three spiro-
metric maneuvers in order to obtain a minimum of two accept-
able and reproducible values. During the maneuvers both flow-
volume and volume-time curves were monitored online by the 
examiner. After each test, the curves were visually inspected, ar-
tifacts were excluded and the results were selected and evaluated 
according to the ATS/ERS recommendations  [12] . The spirometer 
was calibrated daily using a calibration pump supplied by the 
manufacturer. In addition, daily self-testing of the examiners was 
done.
 The indices measured were forced expiratory volume in 1 s 
(FEV 1 ), forced vital capacity (FVC), the ratio FEV 1 /FVC, peak ex-
piratory flow (PEF), and forced expiratory flow rates taken from 
the trial with the largest sum of FEV 1 and FVC at 25, 50 and 75% 
of exhaled FVC (FEF 25 , FEF 50 and FEF 75 ).
 Known acute or chronic respiratory diseases and smoking sta-
tus, as well as the presence of non-lung diseases (cardiac, gastro-
intestinal, renal, neurological and eye diseases as well as diabetes 
mellitus and cancer) were assessed by a detailed questionnaire 
within the comprehensive KORA assessments. Standing height 
and weight were measured on the day of examination with the 
subjects wearing light clothes without shoes. After the exclusion 
of subjects with a history of respiratory diseases such as asthma 
or COPD and ever-smokers, the final sample for the generation of 
reference values comprised 311 subjects aged 42–62 years from 
KORA-F4, and 281 subjects aged 65–89 years from KORA-Age. 
Descriptive data of the cohorts are shown in  table 1 a, and the age 
distribution is shown in  table 1 b.
 Statistical Analyses 
 Quantile regression models  [13] were used to derive reference 
equations. Prediction equations were derived for both the median 
and the lower limit of normal (LLN), i.e. the 5th percentile. Since 
body mass index (BMI, computed as weight over height-squared) 
has been reported to have a significant influence on spirometric 
indices  [14, 15] , a sex-specific quantile regression model was test-
ed with age, height and BMI as predictors. However, in the present 
study, BMI was nonsignificant for all lung function parameters 
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except for the FEV 1 and FVC median in men, and the FVC and 
FEV 1 /FVC median as well as the FVC LLN in women and had 
only minor effects on the quality of the fit. These findings are in 
line with a recent study demonstrating that apart from sex, age 
and height other determinants explain only a small fraction of 
lung function variance  [16] . The present analysis was thus re-
stricted to sex-specific regression models describing the relation-
ship between lung function indices (LF), age and height.
 Two types of regression models were analysed, either additive 
polynomial, LF = b 0 + b 1  ! height + b 2  ! height 2 + b 3  ! age + b 4 
 ! age 2 , or as a power law with various functions of age, LF = e k 1 
 ! height k 2  ! f(age), based on the approach by Cole  [17] . To per-
form the regression analysis for the power law model, the loga-
rithm of LF was analysed against the logarithm of height and 
functions of age. It turned out that different versions of the age 
relationship did not improve the prediction over that of a linear 
age term against the logarithm of LF. Regarding the quality of the 
fit, the power law model was superior to the additive model for all 
LF. Thus, the multiplicative model with a linear age term was cho-
sen as the final model for prediction [ln(LF) = k 1 + k 2  ln(height) 
+ k 3  age].
 In a second step, the spirometric values observed were com-
pared with prediction equations proposed by the ECCS  [4] and 
recent studies  [2, 3, 5, 6] . Differences between the predicted and 
the observed values were expressed as the mean difference in per-
cent of the mean observed values. In addition, the proportion of 
observed values below the predicted LLN of the respective refer-
ence equations was determined. Bland-Altman plots  [18] were 
generated to visualize the differences between predicted values 
based on the equations from the present study and those from the 
other studies. 
 All analyses were performed using the statistical software R, 
version 2.11.1.  [19] , and p values  ! 0.05 were considered statisti-
cally significant. Additional graphs were generated using the soft-
ware package Sigmaplot (Systat Software, San Jose, Calif., USA). 
 Results 
 Data of flow-volume curves are shown in  table 2 , sep-
arately for the KORA-F4 and KORA-Age cohorts. The 
equations for the median and 5th percentile (LLN) are 
provided in  table 3 a and b. As can be seen in  table 4 a and 
b, the values of FEV 1 and FVC in the present study were 
higher than those in other studies. The differences ranged 
between 2.6 and 18.3% in men and 2.8 and 21.2% in wom-
en. The percentages of values below the LLN also differed 
from other studies. These percentages mostly ranged be-
low 2% (instead of 5%), with the exception of the FEV 1 in 
men (8.5%) in the study by Koch et al.  [3] . The differenc-
es in the prediction equations for FEV 1 and FVC also be-
came obvious in the Bland-Altman plots ( fig. 1 a, b). The 
greatest difference in the predicted FEV 1 and FVC oc-
curred in comparison to the study by Smolej-Narancic et 
al.  [6] and the ECCS values  [4] . 
 Regarding the ratio FEV 1 /FVC, the values observed in 
the present study were close to the data by Falaschetti et 
Table 1.  Samples from KORA-F4 and KORA-Age
a    Descriptive data, mean 8 SD or percentage
KORA-F4 K ORA-Age
men women me n women
Subjects, n 114 197 98 183
Age, years 52.385.7 52.385.9 75.986.1 76.586.1
Height, cm 176.686.6 162.785.9 170.886.5 157.686.3
Weight, kg 85.2811.9 69.9812.7 80.6811.4 69.8810.9
BMI 27.483.7 26.484.7 27.683.5 28.184.2
Prevalence of non-lung diseases, % 19.3 26.4 54.1 68.9
b    Age distribution
Age Men, n (%) Women, n (%)
40–49 years 45 (21.2) 76 (20.0)
50–59 years 58 (27.4) 100 (26.3)
60–69 years 30 (14.2) 54 (14.2)
70–79 years 51 (24.1) 89 (23.4)
80–89 years 28 (13.2) 61 (16.1)
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Table 2.  Data of flow-volume curves from KORA-F4 and KORA-Age, median (25th; 75th percentile)
KORA-F4 K ORA-Age
men women me n women
FVC, l 5.07 (4.57; 5.72) 3.63 (3.23; 4.10) 4.11 (3.72; 4.45) 2.75 (2.41; 3.13)
FEV1, l 4.14 (3.67; 4.54) 2.87 (2.60; 3.31) 3.17 (2.69; 3.57) 2.10 (1.84; 2.42)
FEV1/FVC 0.80 (0.77; 0.82) 0.80 (0.77; 0.83) 0.76 (0.73; 0.81) 0.77 (0.73; 0.81)
PEF, l ! s–1 9.24 (7.90; 10.62) 6.32 (5.47; 7.15) 7.24 (5.92; 8.15) 4.89 (3.98; 5.94)
FEF25, l ! s–1 8.24 (7.18; 9.31) 5.74 (4.97; 6.65) 6.34 (5.39; 7.48) 4.47 (3.64; 5.37)
FEF50, l ! s–1 4.78 (4.10; 5.67) 3.60 (3.01; 4.30) 3.51 (2.79; 4.38) 2.49 (1.81; 3.12)
FEF75, l ! s–1 1.49 (1.24; 1.89) 1.10 (0.84; 1.43) 0.88 (0.62; 1.22) 0.56 (0.42; 0.77)
Table 3. Reference equations
a For men
50th percentile
FEV1, l exp(–7.0582685 + 1.7333992 ! ln(H) – 0.0094511 ! A)
FVC, l exp(–8.0537240 + 1.9555357 ! ln(H) – 0.0078653 ! A)
FEV1/FVC exp(1.3632831 – 0.2818021 ! ln(H) – 0.0024269 ! A)
PEF, l ! s–1 exp(–2.5959640 + 1.0137804 ! ln(H) – 0.0083959 ! A)
FEF25, l ! s–1 exp(–2.9874839 + 1.0779635 ! ln(H) – 0.0092600 ! A)
FEF50, l ! s–1 exp(0.1378636 + 0.4205740 ! ln(H) – 0.0137427 ! A)
FEF75, l ! s–1 exp(–7.4480822 + 1.7448540 ! ln(H) – 0.0222180 ! A)
5th percentile (LLN)
FEV1, l exp(–8.3950574 + 1.9921763 ! ln(H) – 0.0141056 ! A)
FVC, l exp(–8.0982157 + 1.9420799 ! ln(H) – 0.0099251 ! A)
FEV1/FVC exp(2.8334625 – 0.5283780 ! ln(H) – 0.0078468 ! A)
PEF, l ! s–1 exp(–3.5547460 + 1.2103164 ! ln(H) – 0.0158704 ! A)
FEF25, l ! s–1 exp(–4.3742809 + 1.3784100 ! ln(H) – 0.0190698 ! A)
FEF50, l ! s–1 exp(–4.6945760 + 1.3988833 ! ln(H) – 0.0270016 ! A)
FEF75, l ! s–1 exp(–6.0518646 + 1.5263951 ! ln(H) – 0.0364690 ! A)
b For women
50th percentile
FEV1, l exp(–9.8813308 + 2.2680933 ! ln(H) – 0.0111944 ! A)
FVC, l exp(–10.8652593 + 2.4767262 ! ln(H) – 0.0085479 ! A)
FEV1/FVC exp(1.8917901 – 0.3936925 ! ln(H) – 0.0020476 ! A)
PEF, l ! s–1 exp(–5.6346321 + 1.5706259 ! ln(H) – 0.0095855 ! A)
FEF25, l ! s–1 exp(–4.6846464 + 1.3519360 ! ln(H) – 0.0086867 ! A)
FEF50, l ! s–1 exp(0.4949622 + 0.3042329 ! ln(H) – 0.0147274 ! A)
FEF75, l ! s–1 exp(–0.9308838 + 0.4544576 ! ln(H) – 0.0253354 ! A)
5th percentile (LLN)
FEV1, l exp(–7.9236784 + 1.8464260 ! ln(H) – 0.0125501 ! A)
FVC, l exp(–10.8547314 + 2.4425959 ! ln(H) – 0.0098406 ! A)
FEV1/FVC exp(1.6130399 – 0.3287409 ! ln(H) – 0.0048989 ! A)
PEF, l ! s–1 exp(–8.3982765 + 2.0735135 ! ln(H) – 0.0129122 ! A)
FEF25, l ! s–1 exp(–7.1508550 + 1.8017099 ! ln(H) – 0.0127377 ! A)
FEF50, l ! s–1 exp(–1.0823057 + 0.6561240 ! ln(H) – 0.0269702 ! A)
FEF75, l ! s–1 exp(–4.0615846 + 1.0931529 ! ln(H) – 0.0366013 ! A)
 A = Age (years); H = height (cm).
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al.  [5]  and Kuster et al.  [2] (mean differences –0.32% to 
–2.23%, respectively), but markedly lower than Koch et 
al.  [3] . Importantly, a steeper decrease occurred in both 
sexes, especially in the LLN. This is illustrated for a spe-
cific example in  figure 2 .
 The differences between the forced expiratory flow 
rates and those of other studies were heterogeneous. 
While PEF and FEF 25 were generally in accordance with 
the ECCS mean values  [4] , they were markedly lower 
(about 15% for PEF and 6% for FEF 25 ) than those pre-
dicted by Kuster et al.  [2] . This difference was lower and 
even became opposite for FEF 50 and FEF 75 , particularly 
in men. The LLN for PEF in the current study was mark-
edly lower than that predicted by Kuster et al.  [2] and the 
ECCS  [4] . For the other forced expiratory flow rates the 
LLN values of the present study tended to be higher than 
the ECCS values in late adulthood, but were in good 
agreement with the values supplied by Kuster et al.  [2] for 
subjects over 65 years of age. This is illustrated by an ex-
ample in  figure 3 .
 Discussion 
 The present study provides up-to-date reference val-
ues of lung function in middle and advanced age. The 
equations for the median and LLN for indices of flow-
volume curves including forced expiratory flow rates are 
based on a random population sample of 592 never-
smoking subjects without a history of respiratory disease. 
As the number of subjects thinned out towards the ends 
of the age and height ranges, thus diminishing predictive 
reliability, we consider the use of our equations as justi-
fied for an age of 45–85 years, and for heights of 160–190 
cm in men and 145–175 cm in women.
 Reference values for lung function parameters have of-
ten been based on standard multiple regression models. 
However, this approach requires data properties that
may be violated for spirometric indices, e.g. a normally 
distributed outcome variable and homoscedasticity.
To avoid these problems, we used quantile regression, a 
method that has recently been applied to model spiro-
metric data  [3, 14] . In contrast to standard regression, 
quantile regression requires no assumption on outcome 
distribution and is more robust against data outliers or 
skewed distributions. It allows an adequate estimation of 
the percentiles of the target variable even if there is a 
strong dependence on covariates such as height or age 
 [20] . As an alternative approach, generalized additive 
models for location, scale and shape (GAMLSS)  [21] have 
Table 4. Differences between observed values and predictions
[2–6]
a For men
Parameter Study Mean dif-
ference, %
Observed values 
below LLN, %
FEV1 Koch et al. 2.5891 8.4906
Smolej-Narancic et al. 18.0199 0
Falaschetti et al. 11.1665 1.4151
Kuster et al. 10.1728 1.8868
ECCS 13.7025 0
FVC Koch et al. 7.0920 3.3019
Smolej-Narancic et al. 18.3201 0
Falaschetti et al. 9.1528 0.4717
Kuster et al. 10.5713 0.9434
ECCS 13.5606 0.9434
FEV1/FVC Koch et al. –6.0986 8.9623
Falaschetti et al. –0.3921 1.4151
Kuster et al. –0.3264 4.2453
ECCS 2.9786 1.8868
PEF Smolej-Narancic et al. 2.1244 5.6604
Kuster et al.                         –16.5507             21.2264
ECCS 2.3230             12.7358
FEF25 Kuster et al. –4.8930 5.6604
ECCS 1.4061 4.2453
FEF50 Kuster et al. 9.1512 3.3019
ECCS 0.3071 2.3585
FEF75 Kuster et al. 11.5213 1.8868
ECCS                                    –18.7135 0
b For women
FEV1 Koch et al. 2.8317 1.3158
Smolej-Narancic et al. 18.9824 0.2632
Falaschetti et al. 11.6610 1.0526
Kuster et al. 10.6383 1.3158
ECCS 16.0669 0.2632
FVC Koch et al. 12.3886 1.0526
Smolej-Narancic et al. 20.7200 0.2632
Falaschetti et al. 12.9147 0.2632
Kuster et al. 11.6468 0.2632
ECCS 21.2302 0
FEV1/FVC Koch et al. –6.0082              27.1053
Falaschetti et al. –1.3395 5.0000
Kuster et al. –2.2284 4.2105
ECCS 1.8187 1.5789
PEF Smolej-Narancic et al. 12.1155 0.2632
Kuster et al.                         –15.8272            20.2632
ECCS –2.3073              13.9474
FEF25 Kuster et al. –7.2208 8.4211
ECCS 0.0724 1.0526
FEF50 Kuster et al. 2.7279 3.9474
ECCS                                    –11.2562 3.6842
FEF75 Kuster et al. 1.7020 1.5789
ECCS                                   –32.1169 0
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 Fig. 1.  a Bland-Altman plots for FEV 1 in women and men. 
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 Fig. 1.  b Bland-Altman plots for FVC in women and men [2–6].
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been applied  [22] . This technique requires a distribution-
al assumption for the outcome variable whose parameters 
are modelled and percentiles derived, as opposed to 
quantile regression where specific percentiles are mod-
elled separately. While a distributional assumption has 
been shown to be possibly inadequate in special cases of 
bimodality  [23] , comparisons between quantile regres-
sion and GAMLSS have demonstrated similar results for 
both methods  [24, 25] . In general, equations resulting 
from quantile regression may facilitate the interpretation 
of relationships between variables compared to the rather 
abstract results generated by GAMLSS.
 A major finding of the present study was the observa-
tion of higher values for FEV 1 and FVC compared to oth-
er reference datasets. While such a difference has been 
described several times for the ECCS equations, our val-
ues are also greater, though to a lesser extent, than recent 
data  [2, 5] . In comparison to the study by Falaschetti et al. 
 [5] , this difference was as high as about 300 ml for wom-
en at the age of 65 years, equivalent to an age difference 
of about 12 years. This suggests that from around the 
sixth decade of life onwards there might be differences in 
lung function between white Caucasian populations 
from different regions. The agreement of the present 
FEV 1 values for men and women with the study by Koch 
et al.  [3] , which also describes populations from Germa-
ny, is considerably better compared to the other studies 
whereas in relation to the equations by Kuster et al.  [2] 
there is a clear deviation towards higher values ( table 4 a, 
b). On the other hand, our observations for PEF and 
FEF 25 on average were markedly below the predictions by 
Kuster et al.  [2] . However, as the distribution of data for 
these indices was skewed, a comparison of mean values 
has to be considered with some caution. In addition, the 
equations by Kuster et al.  [2] are based on volunteers who 
might have introduced a selection bias towards subjects 
5040
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 Fig. 2. Plots of the predicted mean/median and LLN for FEV 1 /FVC against age in women (height = 160 cm) 
[2–5].
 
Fig. 3. Plots of the predicted LLN for FEF 75 against age in women 
(height = 160 cm) [2, 4].
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with a better general health than in the present popula-
tion sample. It may also be that in advanced age subtle 
differences in the combination of inherited, environmen-
tal and lifestyle factors become more apparent, leading to 
lung function differences even between geographically 
proximate regions. This should probably be kept in mind 
when using prediction equations for this age group. Even 
if in clinical applications the impact might be not very 
high, such differences could be misleading in the analysis 
of large populations with high statistical power and mul-
tiple differences in the influencing factors.
 One possibility that could have led to rather high val-
ues of FEV 1 and FVC in our study is a bias towards health-
ier subjects of advanced age, since the participants visited 
the study center for a detailed clinical examination. Con-
versely, the health status of subjects who did not visit the 
study center was possibly lower on average, even if they 
would have been identified as healthy with regard to the 
lung on the basis of their clinical history. There seems to 
be no reason to cast doubt on the quality of the equipment 
used in this and other recent studies as a potential expla-
nation of the differences. 
 Remarkably, the equations for the ratio FEV 1 /FVC not 
only showed a decrease with age but also a broadening of 
the normal range for both sexes. This increase in varia-
tion might be a manifestation of interindividual differ-
ences in lung ageing that become more and more pro-
nounced with age. As our subjects were healthy accord-
ing to their clinical history, this suggests the need for 
caution when diagnosing COPD in advanced age. While 
it has to be kept in mind that we evaluated prebroncho-
dilator values, the postbronchodilator results available in 
75% of the KORA-F4 subjects from the above analysis 
only showed a mean increase of 2% in FEV 1 /FVC. The 
application of the present FEV 1 /FVC LLN equations to 
the complete KORA-F4 and KORA-Age cohorts, for the 
age and height ranges specified above, results in 17% of 
subjects below the LLN compared to 10% below the ratio 
0.7 in KORA-F4 ( ^  62 years) and 8% of subjects below the 
LLN compared to 23% below 0.7 in KORA-Age ( 6 65 
years). These results are in accordance with previous 
findings, criticizing the use of the fixed ratio for a pos-
sible underestimation of bronchial obstruction in the 
younger age group and, more pronounced, an overesti-
mation in the older age group from the sixth decade of 
life onwards  [26, 27] . On the other hand, the fixed ratio 
has the advantage of simplicity and is independent of 
possibly inadequate reference values  [28] . To which ex-
tent a low value of this ratio can be considered compatible 
with being ‘healthy’ could be assessed in studies which 
aim at the predictive value of lung function independent 
of lung disease. A recent study found that individuals 
with a FEV 1 /FVC ratio below 0.7 but above the LLN had 
a worse self-reported health-related quality of life than 
those with FEV 1 /FVC  6 0.7, while no differences were 
found in respiratory exacerbations, dyspnea, physical ac-
tivity, or six minute walking distance  [29] . In the end, for 
a reliable diagnosis, any spirometric criterion should be 
complemented by more advanced measurements like 
body plethysmography as well as information gained 
from thorough anamnesis and, ideally, individual lung 
function history.
 It also has to be acknowledged that we used cross-sec-
tional data. The relationship between lung function pa-
rameters and age might contain secular trends, e.g. to-
wards higher lung function values in general  [30] . This 
would result in a steeper decline in our equations than 
expected in a follow-up. To explore this relationship, 
high-quality longitudinal lung function data are needed 
for the increasing population of advanced age. Recent 
data, however, do not support the existence of such a sec-
ular trend  [31] .
 We put special emphasis on obtaining high-quality 
data for the whole flow-volume curve, including the flow 
rates at middle and low lung volume. This was considered 
important as these indices have often been taken as indi-
cators of changes in small airway function, being indica-
tive of the beginning of airway disease. Although they 
markedly depend on the cooperation of the subject dur-
ing the breathing maneuvers, they are still the only wide-
spread available marker of such changes. It is reassuring 
that the predicted values of FEF 50 and FEF 75 were in ac-
cordance with those of another recent study. However, 
they were higher than the ECCS values (see  fig. 3 ). Thus, 
the use of ECCS values may lead to an underestimation 
of such changes, which are more subtle than those of the 
ratio FEV 1 /FVC but nonetheless informative provided 
that the measurements are valid.
 In conclusion, our analysis provides reference equa-
tions for all common indices of flow-volume curves in 
never-smoking subjects aged 45–85 years without respi-
ratory disease, according to a comprehensive assess-
ment of their health status. Although generally compa-
rable to published data, the results point towards differ-
ences in common measures. This suggests that there 
might be some regional differences of lung function 
within the Caucasian population of advanced age in Eu-
rope.
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